CORONAVIRUS (COVID-19) and UBC’s response: please review the general information and FAQs and Postdoc-specific information.

Postdoctoral Research Fellowship in Pharmacogenomics and Clinical Pharmacology with a Focus on Adverse Drug Reactions

Posting Expiry

Please refer to reference number PDFO-55234 when applying for this position.

 

Departments of Medical Genetics and Pediatrics, Faculty of Medicine

Faculty of Pharmaceutical Sciences

University of British Columbia

Successful candidates will join the laboratories of Dr. Colin Ross and Dr. Bruce Carleton and the multi-centre research team of the Canadian Pharmacogenomics Network for Drug Safety (CPNDS).

We are seeking scientists to lead research projects with a specific focus on the genetic determinants of severe adverse drug reactions (ADRs). Potential projects focus on severe ADRs to a range of different medications. The successful candidate would be expected to have a solid grasp of the fields of genetics and/or genomics and experience in pharmacology and/or bioinformatics analysis tools and data analysis would be an asset. The successful candidate must exhibit excellent communication skills; a demonstrated potential for excellence in research productivity; a Ph.D., or M.D., or Pharm.D., or equivalent degree. The successful candidate will seek to share their research findings through publications, presentations, and other knowledge transfer activities. They will collaborate with various parties including internal and external researchers, stakeholders and national and international bodies. In addition, the successful candidate should demonstrate some experience in writing or assisting with the writing of grant applications.

CPNDS is an energetic, nation-wide, multidisciplinary consortium of researchers and clinicians from hospitals and universities that was established to improve drug safety. CPNDS has catalyzed national and international collaborations and established an active surveillance network to identify patients that have suffered severe ADRs across Canada. The research program applies innovative, large-scale genotyping and DNA sequencing approaches to identify the genetic and/or clinical factors of severe ADRs and to develop predictive tests for safer medicine. The CPNDS includes outstanding infrastructure support and state-of-the-art facilities.

Salary will be commensurate with qualifications and experience. The period of funding is 2-3 years, with 3 years being preferred given the complexity of the work involved.

UBC hires on the basis of merit and is committed to employment equity. All qualified persons are encouraged to apply. UBC is strongly committed to diversity within its community and especially welcomes applications from visible minority group members, women, Aboriginal persons, persons with disabilities, personal of any sexual orientation or gender identity, and others who may contribute to the further diversification of ideas. However, Canadian and permanent residents of Canada will be given priority.

Applications, accompanied by a cover letter stating their research interests, detailed curriculum vitae including a list of your publications and the names of three potential references, should be directed to admin@popi.ubc.ca with “Postdoc Position – PGx & ADRs” listed in the subject line. 

This offer is conditional upon successful completion of a Criminal Record Check.

How to apply?

Please send applications to admin@popi.ubc.ca and refer to reference number PDFO-55234.

Desired start date: 15 Jan 2022
Duration: Fixed term / Temporary
Contract Type: Full Time